Treatment of Staphylococcal Device Infections: Synergistic Daptomycin With Ceftaroline Versus Rifampin-Adjunct Therapy

This is a single-center retrospective observational cohort study comparing daptomycin/ceftaroline combination therapy with rifampin-adjunct therapy for the treatment of staphylococcal device infections. The results of this study support use of the daptomycin/ceftaroline as an alternative or salvage...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Amy T, Cosimi, Reese A, Bochan, Markian R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075485/
https://www.ncbi.nlm.nih.gov/pubmed/32195290
http://dx.doi.org/10.1093/ofid/ofaa072
_version_ 1783507047673757696
author Chang, Amy T
Cosimi, Reese A
Bochan, Markian R
author_facet Chang, Amy T
Cosimi, Reese A
Bochan, Markian R
author_sort Chang, Amy T
collection PubMed
description This is a single-center retrospective observational cohort study comparing daptomycin/ceftaroline combination therapy with rifampin-adjunct therapy for the treatment of staphylococcal device infections. The results of this study support use of the daptomycin/ceftaroline as an alternative or salvage option to standard of care.
format Online
Article
Text
id pubmed-7075485
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-70754852020-03-19 Treatment of Staphylococcal Device Infections: Synergistic Daptomycin With Ceftaroline Versus Rifampin-Adjunct Therapy Chang, Amy T Cosimi, Reese A Bochan, Markian R Open Forum Infect Dis Brief Report This is a single-center retrospective observational cohort study comparing daptomycin/ceftaroline combination therapy with rifampin-adjunct therapy for the treatment of staphylococcal device infections. The results of this study support use of the daptomycin/ceftaroline as an alternative or salvage option to standard of care. Oxford University Press 2020-02-28 /pmc/articles/PMC7075485/ /pubmed/32195290 http://dx.doi.org/10.1093/ofid/ofaa072 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Report
Chang, Amy T
Cosimi, Reese A
Bochan, Markian R
Treatment of Staphylococcal Device Infections: Synergistic Daptomycin With Ceftaroline Versus Rifampin-Adjunct Therapy
title Treatment of Staphylococcal Device Infections: Synergistic Daptomycin With Ceftaroline Versus Rifampin-Adjunct Therapy
title_full Treatment of Staphylococcal Device Infections: Synergistic Daptomycin With Ceftaroline Versus Rifampin-Adjunct Therapy
title_fullStr Treatment of Staphylococcal Device Infections: Synergistic Daptomycin With Ceftaroline Versus Rifampin-Adjunct Therapy
title_full_unstemmed Treatment of Staphylococcal Device Infections: Synergistic Daptomycin With Ceftaroline Versus Rifampin-Adjunct Therapy
title_short Treatment of Staphylococcal Device Infections: Synergistic Daptomycin With Ceftaroline Versus Rifampin-Adjunct Therapy
title_sort treatment of staphylococcal device infections: synergistic daptomycin with ceftaroline versus rifampin-adjunct therapy
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7075485/
https://www.ncbi.nlm.nih.gov/pubmed/32195290
http://dx.doi.org/10.1093/ofid/ofaa072
work_keys_str_mv AT changamyt treatmentofstaphylococcaldeviceinfectionssynergisticdaptomycinwithceftarolineversusrifampinadjuncttherapy
AT cosimireesea treatmentofstaphylococcaldeviceinfectionssynergisticdaptomycinwithceftarolineversusrifampinadjuncttherapy
AT bochanmarkianr treatmentofstaphylococcaldeviceinfectionssynergisticdaptomycinwithceftarolineversusrifampinadjuncttherapy

Ejemplares similares